WCM
CALA

Weld Capital Management’s Calithera Biosciences, Inc CALA Stock Holding History

Weld Capital Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,464
Closed -$214K – 1029
2019
Q3 		$214K Buy
3,464
+2,947
+570% +$236K 0.04% 683
2019
Q2 		$40K Buy
+517
New +$58.7K 0.01% 706

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Weld Capital Management's CALA Position: Q4 2019 in Review

Weld Capital Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2019, closing a stake of 3,464 shares — an estimated $214K sold.

Weld Capital Management first reported a position in CALA in Q2 2019 and held it in 2 quarters. The position peaked at $214K in Q3 2019. 82 funds tracked by Wall St. Rank hold CALA as of Q4 2019.

  • Weld Capital Management reported no remaining Calithera Biosciences, Inc position as of Q4 2019 after selling out during the quarter.
  • Weld Capital Management sold 3,464 Calithera Biosciences, Inc shares in Q4 2019, an estimated $214K.
  • Weld Capital Management first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 2 quarters.
  • Weld Capital Management's Calithera Biosciences, Inc position peaked at $214K in Q3 2019.
  • 82 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2019.

Based on Weld Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.